RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA (R/R B-NHL)

Clinical trials for RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA (R/R B-NHL) explained in plain language.

Never miss a new study

Get alerted when new RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA (R/R B-NHL) trials appear

Sign up with your email to follow new studies for RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA (R/R B-NHL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Experimental cell injection aims to fight aggressive blood cancer

Disease control Not yet recruiting

This study is testing a new cell-based treatment for adults with B-cell non-Hodgkin lymphoma that has come back or hasn't responded to standard therapies. The main goals are to see if the treatment is safe and to find the best dose. Researchers will track how patients do for up t…

Matched conditions: RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA (R/R B-NHL)

Phase: NA • Sponsor: Donghua Zhang • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA (R/R B-NHL)

Get alerted when new RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA (R/R B-NHL) trials appear

Experimental cell injection aims to fight aggressive blood cancer